Altimmune, Inc. (ALT)
NASDAQ·Healthcare·Biotechnology
$3.19
-6.45%
Mkt Cap $632.04M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$6.25
Range $2.50 – $10.00
Implied Upside
+95.9%
Consensus $6.25 vs current $3.19
NASDAQ·Healthcare·Biotechnology
$3.19
-6.45%
Mkt Cap $632.04M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$6.25
Range $2.50 – $10.00
+95.9%
Consensus $6.25 vs current $3.19